(Q42495468)

1 November 2017

The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia (English)

1 reference

polycystic ovary syndrome

1 November 2017

0 references

1 reference

1 reference

G Misichronis

1

1 reference

1 November 2017

N A Georgopoulos

2

1 reference

1 November 2017

D J Marioli

3

1 reference

1 November 2017

A K Armeni

4

1 reference

1 November 2017

I Katsikis

5

1 reference

1 November 2017

A D Piouka

6

1 reference

1 November 2017

A D Saltamavros

7

1 reference

1 November 2017

N D Roupas

8

1 reference

1 November 2017

D Panidis

9

1 reference

1 November 2017

4 October 2011

1 reference

Gynecological Endocrinology

1 November 2017

1 reference

1 November 2017

28

1 reference

1 November 2017

4

1 reference

1 November 2017

249-252

1 reference

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Evaluation of assays available to measure free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Plasma androgens in patients with the polycystic overy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

Lack of association between common polymorphisms in the 17β-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613965

10.3109/09513590.2011.613965

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference